ArticleFrontiers in chemistry2025

HIF1A acts as target of XiHuang Pill in the treatment of papillary thyroid cancer by regulating dedifferentiation.

Xu-Zhe Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.